Chemotherapy-induced posterior reversible encephalopathy syndrome: Three case reports

RATIONALE: Posterior reversible encephalopathy syndrome (PRES) has been associated with the use of several medications, including chemotherapeutic agents. PATIENT CONCERNS: A 65-year-old woman was diagnosed with adenocarcinoma of the ovary, after sixth-line treatment with topotecan, at the beginning...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Medicine (Baltimore)
Auteurs principaux: Cacho-Díaz, Bernardo, Lorenzana-Mendoza, Nydia A., Salmerón-Moreno, Karen, Reyes-Soto, Gervith, Castillo-Rangel, Carlos, Corona-Cedillo, Roberto, Escobar-Ceballos, Salvador, de la Garza-Salazar, Jaime G.
Format: Artigo
Langue:Inglês
Publié: Wolters Kluwer Health 2019
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6531111/
https://ncbi.nlm.nih.gov/pubmed/31083272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000015691
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires